Allogene Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $642.8M
Liabilities Breakdown FY2023
Total Liabilities: $130.6M
Asset Breakdown
Total Assets: $642.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $83.2M | 12.9% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $99.5M | 15.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $460.2M | 71.6% |
Liabilities Breakdown
Total Liabilities: $130.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.9M | 4.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $124.7M | 95.5% |